PAR2 activation has been linked to cancer progression, especially metastasis and angiogenesis [6], [7], [8], [9], as well as pro-inflammatory [10], [11], [12], [13], [14], [15] and anti-inflammatory [16], [17] properties depending on the system, although this is controversial and not well understood. The gene discussed is F2RL1; the disease is cancer.